… The results demonstrated that we have creatively developed the first Nb against SARS-CoV-2
with the inhale delivery potential. The novel way of delivery may offer patients more …

… reviewed the potentials of Nanobodies in Covid-19 treatment. … SARS-CoV-2 neutralization
by Nanobodies prevents viral … , Nanobodies, are particularly suited for delivery by inhalation …

… potent single-domain nanobody, NIH-CoVnb-112, specific for the receptor-binding domain
(RBD) of SARS-CoV-2… support for using nanobodies as potentially inhaled therapeutics, there …

… So, delivering cytotoxic molecules via nanotubes ensures that decidual nK cells protect … The
protective potential of SARS- CoV-2 neutralizing antibodies (nAbs) has not been validated in …

… to improve efficacy and delivery of antibody therapies against … of inhalation therapy (including
orally and nasally inhaled) of … us to be better equipped to tackle possible future pandemics. …

… -CoV-2 as broadly as possible, binding to the variant RBDs … that the nanobodies Ma28H02
and Ma28H11 are highly potent … a delivery system to cover these epithelia with nanobody. …

… Neutralizing nanobodies (Nbs) are a potential therapeutic … Nbs are delivered directly to the
lungs by an inhaler given their … lung RSV titers by the pulmonary administration of inhalation ( …

… inhalation device and summarize evidence from animal models and early clinical trials
supporting the respiratory delivery (… , potentially hampering their full development: eg, nanobodies …

… low efficiency of intravenously delivering these relatively large … the in vivo neutralizing
activities of mAbs (34–36), drive potential … Compared to 8 hours after inhalation, we found that the …

… arsenal against SARS-CoV-1, provides potential therapeutic … Inhalation of conventional
antibodies as well as Nbs has been … To test 2-3-Fc for protection in vivo via in delivery, four dose …